BioSpace News Archive

Kaleido Biosciences, Inc. today announced that it will host a virtual R&D Presentation on October 5, 2021, at 8 a.m. ET.

Mindset Pharma Inc. today announced that, in addition to its potential lead new chemical entity (“NCE”) candidate, MSP-4018, the Company has identified two additional pipeline opportunities from its Family 4 compounds, MSP-4019 and MSP-4020.

Prelude Corporation announced today the addition of Karuna Mittal , Ph.D. as Director of Research and Development.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced plans to release its financial results for the third quarter of 2021 on November 4, 2021 after the close of the financial markets.

MannKind Corporation, a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced that it has entered into a sale-leaseback transaction with an affiliate of Creative Manufacturing Properties, which will generate $102.25 million in gross proceeds upon closing.

Psomagen Inc., a CLIA-certified laboratory and at-home testing provider, has launched a vaginal microbiome health study in recognition of National Women’s Health and Fitness Day, which is celebrated each year on the last day of September.

IntelGenx Corp. (TSXV:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that its co-development and commercialization partner for Tadalafil oral films for the treatment of erectile dysfunction (“ED”) and benign prostatic hyperplasia (BPH) (the “Product”), Aquestive Therapeutics, Inc. (NASDAQ:AQST) (“Aquestive”), has entered into a definitive license and supply agreement (the “Agreement”) with an undisclosed leading men’s health company.

Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, today announced that Dr. Tiago Reis Marques, Chief Executive Officer, will present at the Benzinga Healthcare Small Cap Conference.

It is with profound sadness that Coherus BioSciences, Inc. announces the passing of board member Samuel Nussbaum, M.D. During his distinguished career, Dr. Nussbaum worked as a physician, researcher, professor, and healthcare executive.

PTC Therapeutics, Inc. announced that on Sept. 22, 2021, the company approved non-statutory stock options to purchase an aggregate of 51,400 shares of its common stock and 18,790 restricted stock units, each representing the right to receive one share of its common stock upon vesting, to 47 new employees.